OKYO Pharma (OKYO) Receivables - Net (2021 - 2025)

OKYO Pharma (OKYO) has 5 years of Receivables - Net data on file, last reported at $242342.0 in Q1 2025.

• Receivables - Net for Q1 2025 came in at $242342.0, up 59.5% year-over-year; the trailing twelve-month figure through Mar 2025 was $242342.0 (up 59.5% YoY), and the FY2025 annual result was $242342.0, up 59.5% from the prior year.
• Receivables - Net rose to $242342.0 in Q1 2025 per OKYO's latest filing, from $151938.0 in the prior quarter.
• Over five years, Receivables - Net peaked at $812956.0 in Q1 2022 and troughed at $43370.0 in Q1 2021.
• A 5-year average of $368560.2 and a median of $242342.0 in 2025 frame the typical range for Receivables - Net.
• The sharpest annual moves came in 2022 and 2024: Receivables - Net jumped 1774.47% in 2022, then sank 74.34% in 2024.
• A 5-year view of Receivables - Net shows it stood at $43370.0 in 2021, then jumped by 1774.47% to $812956.0 in 2022, then slipped by 27.16% to $592195.0 in 2023, then sank by 74.34% to $151938.0 in 2024, then soared by 59.5% to $242342.0 in 2025.
• Business Quant data shows OKYO's Receivables - Net at $242342.0 in Q1 2025, $151938.0 in Q1 2024, and $592195.0 in Q1 2023.